Advertisement
Review Article| Volume 37, ISSUE 1, P153-173, March 2023

Update in Human Immunodeficiency Virus and Aging

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Infectious Disease Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. The lancet healthy longevity. Ageing with HIV.
        Lancet Heal Longev. 2022; 3: e119
      2. National Institutes of Health. HIV and older people.
        (Available at:) (Accessed August 21, 2022)
      3. Centers for Disease Control and Prevention. HIV surveillance report.
        (Available at:) (Accessed August 21, 2022)
        • Vance D.
        • McGuiness T.
        • Musgrove K.
        • et al.
        Successful aging and the epidemiology of HIV.
        Clin Interv Aging. 2011; 181https://doi.org/10.2147/CIA.S14726
      4. Centers for Disease Control and Prevention. National profile.
        (Available at:) (Accessed August 20, 2022)
        • Bosh K.A.
        • Johnson A.S.
        • Hernandez A.L.
        • et al.
        Vital signs: deaths among persons with diagnosed HIV Infection, United States, 2010–2018.
        MMWR Morb Mortal Wkly Rep. 2020; https://doi.org/10.15585/mmwr.mm6946a1
        • Oursler K.K.
        • Sorkin J.D.
        HIV and aging.
        Int J Infect Dis. 2016; 53: 59-60
        • Gabuzda D.
        • Jamieson B.D.
        • Collman R.G.
        • et al.
        Pathogenesis of aging and age-related comorbidities in people with HIV: highlights from the HIV ACTION Workshop.
        Pathog Immun. 2020; 5: 143-174
        • Montano M.
        • Bhasin S.
        • D’Aquila R.T.
        • et al.
        Harvard HIV and aging workshop: perspectives and priorities from claude D. Pepper Centers and Centers for AIDS Research.
        AIDS Res Hum Retroviruses. 2019; 35: 999-1012
        • Kennedy B.K.
        • Berger S.L.
        • Brunet A.
        • et al.
        Geroscience: linking aging to chronic disease.
        Cell. 2014; 159: 709-713
        • Montano M.
        • Oursler K.K.
        • Xu K.
        • et al.
        Biological ageing with HIV infection: evaluating the geroscience hypothesis.
        Lancet Heal Longev. 2022; 3: e194-e205
        • Horvath S.
        • Lin D.T.S.
        • Kobor M.S.
        • et al.
        HIV, pathology and epigenetic age acceleration in different human tissues.
        GeroScience. 2022; https://doi.org/10.1007/s11357-022-00560-0
        • Titanji B.K.
        • Gwinn M.
        • Marconi V.C.
        • et al.
        Epigenome-wide epidemiologic studies of human immunodeficiency virus infection, treatment, and disease progression.
        Clin Epigenetics. 2022; 14: 8
        • Zanet D.L.
        • Thorne A.
        • Singer J.
        • et al.
        Association between short leukocyte telomere length and HIV infection in a cohort study: no evidence of a relationship with antiretroviral therapy.
        Clin Infect Dis. 2014; 58: 1322-1332
        • Hunt M.
        • Payne B.A.I.
        Mitochondria and ageing with HIV.
        Curr Opin HIV AIDS. 2020; 15: 101-109
        • McComsey G.A.
        • Daar E.S.
        • O’Riordan M.
        • et al.
        Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202.
        J Infect Dis. 2013; 207: 604-611
        • Sun J.
        • Brown T.T.
        • Samuels D.C.
        • et al.
        The Role of Mitochondrial DNA Variation in Age-Related Decline in Gait Speed among Older Men Living with Human Immunodeficiency Virus.
        Clin Infect Dis. 2018; 67https://doi.org/10.1093/cid/ciy151
        • Ortmeyer H.K.
        • Ryan A.S.
        • Hafer-Macko C.
        • et al.
        Skeletal muscle cellular metabolism in older HIV-infected men.
        Physiol Rep. 2016; 4https://doi.org/10.14814/phy2.12794
        • Masters M.C.
        • Landay A.L.
        • Robbins P.D.
        • et al.
        Chronic HIV Infection and Aging: Application of a Geroscience-Guided Approach.
        J Acquir Immune Defic Syndr. 2022; 89: S34-S46
        • Han X.
        • Lei Q.
        • Xie J.
        • et al.
        Potential regulators of the senescence-associated secretory phenotype during senescence and ageing.
        J Gerontol A Biol Sci Med Sci. 2022; https://doi.org/10.1093/gerona/glac097
        • Franceschi C.
        • Garagnani P.
        • Parini P.
        • et al.
        Inflammaging: a new immune–metabolic viewpoint for age-related diseases.
        Nat Rev Endocrinol. 2018; https://doi.org/10.1038/s41574-018-0059-4
        • Pathai S.
        • Bajillan H.
        • Landay A.L.
        • et al.
        Is HIV a model of accelerated or accentuated aging?.
        J Gerontol - Ser A Biol Sci Med Sci. 2014; 69https://doi.org/10.1093/gerona/glt168
        • De Socio G.V.
        • Pasqualini M.
        • Ricci E.
        • et al.
        Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study.
        BMC Public Health. 2020; 20: 734
        • Shiau S.
        • Arpadi S.M.
        • Yin M.T.
        • et al.
        Patterns of drug use and HIV infection among adults in a nationally representative sample.
        Addict Behav. 2017; https://doi.org/10.1016/j.addbeh.2017.01.015
        • Klein D.B.
        • Leyden W.A.
        • Xu L.
        • et al.
        Declining relative risk for myocardial infarction among HIV-positive compared with HIV-negative individuals with access to care.
        Clin Infect Dis. 2015; https://doi.org/10.1093/cid/civ014
        • Mak G.
        • Zaunders J.J.
        • Bailey M.
        • et al.
        Preservation of gastrointestinal mucosal barrier function and microbiome in patients with controlled HIV infection.
        Front Immunol. 2021; https://doi.org/10.3389/fimmu.2021.688886
        • Tarr P.E.
        • Ledergerber B.
        • Calmy A.
        • et al.
        Subclinical coronary artery disease in Swiss HIV-positive and HIV-negative persons.
        Eur Heart J. 2018; https://doi.org/10.1093/eurheartj/ehy163
        • Sortino O.
        • Phanuphak N.
        • Schuetz A.
        • et al.
        Impact of acute HIV infection and early antiretroviral therapy on the human gut microbiome.
        Open Forum Infect Dis. 2020; https://doi.org/10.1093/ofid/ofz367
        • Lozupone C.A.
        • Li M.
        • Campbell T.B.
        • et al.
        Alterations in the gut microbiota associated with HIV-1 infection.
        Cell Host Microbe. 2013; https://doi.org/10.1016/j.chom.2013.08.006
        • Dinh D.M.
        • Volpe G.E.
        • Duffalo C.
        • et al.
        Intestinal Microbiota, microbial translocation, and systemic inflammation in chronic HIV infection.
        J Infect Dis. 2015; https://doi.org/10.1093/infdis/jiu409
        • Alzahrani J.
        • Hussain T.
        • Simar D.
        • et al.
        Inflammatory and immunometabolic consequences of gut dysfunction in HIV: Parallels with IBD and implications for reservoir persistence and non-AIDS comorbidities.
        EBioMedicine. 2019; 46: 522-531
        • Angelovich T.A.
        • Hearps A.C.
        • Maisa A.
        • et al.
        Viremic and virologically suppressed HIV infection increases age-related changes to monocyte activation equivalent to 12 and 4 years of aging, respectively.
        J Acquir Immune Defic Syndr. 2015; https://doi.org/10.1097/QAI.0000000000000559
        • Psomas C.K.
        • Waters L.
        • Barber T.
        • et al.
        Highlights of the 10th International AIDS Society (IAS) Conference on HIV Science, 21-25 July 2019, Mexico City, Mexico.
        J Virus Eradication. 2019; https://doi.org/10.1016/S2055-6640(20)30035-2
        • Kardashian A.
        • Peters M.G.
        • Tien P.C.
        • et al.
        The Pathogenesis of Liver Disease in People Living With Human Immunodeficiency Virus: The Emerging Role of the Microbiome.
        Clin Liver Dis. 2020; https://doi.org/10.1002/cld.880
        • Jaworowski A.
        • Hearps A.C.
        • Angelovich T.A.
        • et al.
        How monocytes contribute to increased risk of atherosclerosis in virologically-suppressed HIV-positive individuals receiving combination antiretroviral therapy.
        Front Immunol. 2019; https://doi.org/10.3389/fimmu.2019.01378
        • Freiberg M.S.
        • Chang C.C.H.
        • Kuller L.H.
        • et al.
        HIV infection and the risk of acute myocardial infarction.
        JAMA Intern Med. 2013; https://doi.org/10.1001/jamainternmed.2013.3728
        • Scherzer R.
        • Estrella M.
        • Li Y.
        • et al.
        Association of tenofovir exposure with kidney disease risk in HIV infection.
        Aids. 2012; 26: 867-875
        • Scherzer R.
        • Gandhi M.
        • Estrella M.M.
        • et al.
        A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans.
        Aids. 2014; 28: 1289-1295
        • Mocroft A.
        • Kirk O.
        • Reiss P.
        • et al.
        Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.
        Aids. 2010; 24: 1667-1678
        • Tien P.C.
        • Schneider M.F.
        • Cole S.R.
        • et al.
        Antiretroviral therapy exposure and insulin resistance in the women’s interagency HIV study.
        J Acquir Immune Defic Syndr. 2008; 49: 369-376
        • Chawla A.
        • Wang C.
        • Patton C.
        • et al.
        A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population.
        Infect Dis Ther. 2018; 7: 183-195
        • Hasse B.
        • Ledergerber B.
        • Furrer H.
        • et al.
        Morbidity and aging in HIV-infected persons: The swiss HIV cohort study.
        Clin Infect Dis. 2011; 53: 1130-1139
        • Mata-Marín J.A.
        • Martínez-Osio M.H.
        • Arroyo-Anduiza C.I.
        • et al.
        Comorbidities and polypharmacy among HIV-positive patients aged 50 years and over: A case-control study.
        BMC Res Notes. 2019; 12: 1-6
        • Krentz H.B.
        • Cosman I.
        • Lee K.
        • et al.
        Pill burden in HIV infection: 20 Years of experience.
        Antivir Ther. 2012; 17: 833-840
        • Zhou S.
        • Martin K.
        • Corbett A.
        • et al.
        Total daily pill burden in HIV-infected patients in the Southern United States.
        AIDS Patient Care STDS. 2014; 28: 311-317
        • Matchanova A.
        • Woods S.P.
        • Kordovski V.M.
        Operationalizing and evaluating the Frascati criteria for functional decline in diagnosing HIV-associated neurocognitive disorders in adults.
        J Neurovirol. 2020; 26: 155-167
        • Brew B.J.
        • Chan P.
        Update on HIV Dementia and HIV-Associated Neurocognitive Disorders.
        Curr Neurol Neurosci Rep. 2014; 14: 468
        • Letendre S.
        • Ellis R.
        • Tang B.
        12-year cognitive decline is associated with lung disease, diabetes and depression.
        Abstr Virtual. 2021; 29 (2021 Conf Retroviruses Opportunistic Infect Top Antivir Med): 483
        • Ances B.M.
        • Anderson A.M.
        • Letendre S.L.
        CROI 2021: neurologic complications of HIV-1 infection or COVID-19.
        Top Antivir Med. 2021; 29: 334-343
        • Wing E.J.
        HIV and aging.
        Int J Infect Dis. 2016; 53: 61-68
        • Lam J.O.
        • Hou C.E.
        • Hojilla J.C.
        • et al.
        Comparison of dementia risk after age 50 between individuals with and without HIV infection.
        AIDS. 2021; 35: 821-828
        • León R.
        • Reus S.
        • López N.
        • et al.
        Subclinical atherosclerosis in low Framingham risk HIV patients.
        Eur J Clin Invest. 2017; https://doi.org/10.1111/eci.12780
        • Lo J.
        • Abbara S.
        • Shturman L.
        • et al.
        Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in hiv-infected men.
        AIDS. 2010; https://doi.org/10.1097/QAD.0b013e328333ea9e
        • Triant V.A.
        • Perez J.
        • Regan S.
        • et al.
        Cardiovascular risk prediction functions underestimate risk in HIV infection.
        Circulation. 2018; https://doi.org/10.1161/CIRCULATIONAHA.117.028975
        • Feinstein M.J.
        • Nance R.M.
        • Drozd D.R.
        • et al.
        Assessing and refining myocardial infarction risk estimation among patients with human immunodeficiency virus: A study by the Centers for AIDS Research Network of Integrated Clinical Systems.
        JAMA Cardiol. 2017; https://doi.org/10.1001/jamacardio.2016.4494
        • Raggi P.
        • Zona S.
        • Scaglioni R.
        • et al.
        Epicardial adipose tissue and coronary artery calcium predict incident myocardial infarction and death in HIV-infected patients.
        J Cardiovasc Comput Tomogr. 2015; https://doi.org/10.1016/j.jcct.2015.08.002
        • Soares C.
        • Samara A.
        • Yuyun M.F.
        • et al.
        Coronary artery calcification and plaque characteristics in people living with hiv: A systematic review and meta-analysis.
        J Am Heart Assoc. 2021; https://doi.org/10.1161/JAHA.120.019291
        • Feinstein M.J.
        • Hsue P.Y.
        • Benjamin L.A.
        • et al.
        Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the american heart association.
        Circulation. 2019; https://doi.org/10.1161/CIR.0000000000000695
        • Hoffmann U.
        • Lu M.T.
        • Olalere D.
        • et al.
        Rationale and design of the mechanistic substudy of the randomized trial to prevent vascular events in HIV (REPRIEVE): effects of pitavastatin on coronary artery disease and inflammatory biomarkers.
        Am Heart J. 2019; 212: 1-12
        • Crothers K.
        • Huang L.
        • Goulet J.L.
        • et al.
        HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era.
        Am J Respir Crit Care Med. 2011; 183: 388-395
        • Crothers K.
        • Butt A.A.
        • Gibert C.L.
        • et al.
        Increased COPD among HIV-positive compared to HIV-negative veterans.
        Chest. 2006; 130: 1326-1333
      5. Yearsley MM, Diaz PT, Knoell D, Nuovo GJ. Correlation of HIV-1 Detection and Histology in AIDS-Associated Emphysema. Diagnostic Molecular Pathology. 2005;14(1):48–52.

        • Diaz P.T.
        • King M.A.
        • Pacht E.R.
        • et al.
        Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers.
        (Available at:) (Accessed August 24, 2022)
        • Fischer B.M.
        • Pavlisko E.
        • Voynow J.A.
        Pathogenic triad in COPD: Oxidative stress, protease-antiprotease imbalance, and inflammation.
        Int J COPD. 2011; 6: 413-421
        • Deeks S.G.
        • Tracy R.
        • Douek D.C.
        Systemic Effects of Inflammation on Health during Chronic HIV Infection.
        Immunity. 2013; 39: 633-645
        • Cribbs S.K.
        • Crothers K.
        • Morris A.
        Pathogenesis of hiv-related lung disease: Immunity, infection, and inflammation.
        Physiol Rev. 2020; 100: 603-632
        • Byanova K.
        • Kunisaki K.M.
        • Vasquez J.
        • et al.
        Chronic obstructive pulmonary disease in HIV.
        Expert Rev Respir Med. 2021; 15: 71-87
        • Sussenbach A.E.
        • Van Gijzel S.W.L.
        • Lalla-Edward S.T.
        • et al.
        The influence of smoking and HIV infection on pulmonary function.
        South Afr J HIV Med. 2022; 23: 1-7
        • Petrache I.
        • Diab K.
        • Knox K.S.
        • et al.
        HIV associated pulmonary emphysema: A review of the literature and inquiry into its mechanism.
        Thorax. 2008; 63: 463-469
        • Drummond M.B.
        • Merlo C.A.
        • Astemborski J.
        • et al.
        NIH Public Access. 2014; 27: 1303-1311https://doi.org/10.1097/QAD.0b013e32835e395d
        • Gingo M.R.
        • George M.P.
        • Kessinger C.J.
        • et al.
        Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era.
        Am J Respir Crit Care Med. 2010; 182: 790-796
        • Varkila M.R.J.
        • Vos A.G.
        • Barth R.E.
        • et al.
        The association between HIV infection and pulmonary function in a rural African population.
        PLoS One. 2019; 14: 1-12
        • Jia J.
        • Zhu Q.
        • Deng L.
        • et al.
        Treatment outcomes of HIV patients with hepatitis B and C virus co-infections in Southwest China: an observational cohort study.
        Infect Dis Poverty. 2022; 11: 1-7
        • Chammartin F.
        • Lodi S.
        • Logan R.
        • et al.
        Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study.
        Ann Intern Med. 2021; 174: 768-776
        • Kronfli N.
        • Bhatnagar S.R.
        • Hull M.W.
        • et al.
        Trends in cause-specific mortality in HIV-hepatitis C coinfection following hepatitis C treatment scale-up.
        Aids. 2019; 33: 1013-1022
        • Chun H.M.
        • Roediger M.P.
        • Hullsiek K.H.
        • et al.
        Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters.
        J Infect Dis. 2012; https://doi.org/10.1093/infdis/jir720
        • Maurice J.B.
        • Patel A.
        • Scott A.J.
        • et al.
        Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection.
        AIDS. 2017; https://doi.org/10.1097/QAD.0000000000001504
        • Bakasis A.D.
        • Androutsakos T.
        Liver fibrosis during antiretroviral treatment in hiv-infected individuals. Truth or tale?.
        Cells. 2021; https://doi.org/10.3390/cells10051212
        • Neff G.W.
        • Jayaweera D.
        • Sherman K.E.
        Drug-induced liver injury in HIV patients.
        Gastroenterol Hepatol. 2006;
        • Chaudhary S.R.
        • Workeneh B.T.
        • Montez-Rath M.E.
        • et al.
        Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy.
        Nephrol Dial Transplant. 2015; 30: 1734-1740https://doi.org/10.1093/ndt/gfv207
        • Adnani H.
        • Agrawal N.
        • Khatri A.
        • et al.
        Impact of Antiretroviral Therapy on Kidney Disease in HIV Infected Individuals – A Qualitative Systematic Review.
        J Int Assoc Provid AIDS Care. 2022; 21https://doi.org/10.1177/23259582221089194
        • Lener M.S.
        乳鼠心肌提取 HHS Public Access.
        Physiol Behav. 2016; 176: 139-148
        • Choi A.I.
        • Shlipak M.G.
        • Hunt P.W.
        • et al.
        HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy.
        AIDS. 2009; 23: 2143-2149
        • Papeta N.
        • Sterken R.
        • Kiryluk K.
        • et al.
        The molecular pathogenesis of HIV-1 associated nephropathy: Recent advances.
        J Mol Med. 2011; 89: 429-436
        • Samji H.
        • Cescon A.
        • Hogg R.S.
        • et al.
        Closing the gap: Increases in life expectancy among treated HIV-positive individuals in the United States and Canada.
        PLoS One. 2013; 8: 6-13
        • Röling J.
        • Schmid H.
        • Fischereder M.
        • et al.
        HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy.
        Clin Infect Dis. 2006; 42: 1488-1495
        • Jotwani V.
        • Li Y.
        • Grunfeld C.
        • et al.
        Risk factors for ESRD in HIV-infected individuals: Traditional and HIV-related factors.
        Am J Kidney Dis. 2012; 59: 628-635
      6. Szczech LA, Gange SJ, Van Der Horst C, et al. Predictors of Proteinuria and Renal Failure among Women with HIV Infection. Kidney International 2002;61(1):195–202.

        • Estrella M.M.
        • Parekh R.S.
        • Astor B.C.
        • et al.
        Chronic Kidney Disease and Estimates of Kidney Function in HIV Infection: A Cross-Sectional Study in the Multicenter AIDS Cohort Study.
        (Available at:) (Accessed August 21, 2022)
        • Guaraldi G.
        • Orlando G.
        • Zona S.
        • et al.
        Linked references are available on JSTOR for this article : UIHUm MAJOR ARTICLE Premature Age-Related Comorbidities Among HIV-infected Persons Compared With the.
        Gen Popul. 2018; 53: 1120-1126
        • Oursler K.K.
        • Iranmanesh A.
        • Jain C.
        • et al.
        Low Muscle Mass Is Associated with Osteoporosis in Older Adults Living with HIV.
        AIDS Res Hum Retroviruses. 2019;
        • Montoya J.L.
        • Jankowski C.M.
        • O’Brien K.K.
        • et al.
        Evidence-informed practical recommendations for increasing physical activity among persons living with HIV.
        AIDS. 2019; 33: 931-939
        • Starup-Linde J.
        • Rosendahl S.B.
        • Storgaard M.
        • et al.
        Management of Osteoporosis in Patients Living With HIV-A Systematic Review and Meta-analysis.
        J Acquir Immune Defic Syndr. 2020; 83: 1-8
        • Triant V.A.
        • Brown T.T.
        • Lee H.
        • et al.
        Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system.
        J Clin Endocrinol Metab. 2008; 93: 3499-3504
        • Borges Á.H.
        • Hoy J.
        • Florence E.
        • et al.
        Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort.
        Clin Infect Dis. 2017; 64: 1413-1421
        • Brown T.T.
        • Hoy J.
        • Borderi M.
        • et al.
        Recommendations for evaluation and management of bone disease in HIV.
        Clin Infect Dis. 2015; 60: 1242-1251
        • Hawkins K.L.
        • Zhang L.
        • Ng D.K.
        • et al.
        Abdominal obesity, sarcopenia, and osteoporosis are associated with frailty in men living with and without HIV.
        AIDS. 2018; 32: 1257-1266
        • Piggott D.A.
        • Bandeen-Roche K.
        • Mehta S.H.
        • et al.
        Frailty transitions, inflammation, and mortality among persons aging with HIV infection and injection drug use.
        AIDS. 2020; 34: 1217-1225
        • Erlandson K.M.
        • Piggott D.A.
        Frailty and HIV: moving from characterization to intervention.
        Curr HIV/AIDS Rep. 2021; 18: 157-175
        • Hawkins K.L.
        • Brown T.T.
        • Margolick J.B.
        • et al.
        Geriatric syndromes: new frontiers in HIV and sarcopenia.
        Aids. 2017; 31: S137-S146
        • Justice A.C.
        • Tate J.P.
        Strengths and limitations of the veterans aging cohort study index as a measure of physiologic frailty.
        AIDS Res Hum Retroviruses. 2019; 35: 1023-1033
        • Park L.S.
        • Tate J.P.
        • Sigel K.
        • et al.
        Time trends in cancer incidence in persons living with HIV/AIDS in the antiretroviral therapy era: 1997-2012.
        AIDS. 2016; 30: 1795-1806
        • Veyri M.
        • Lavolé A.
        • Choquet S.
        • et al.
        Do people living with HIV face more secondary cancers than general population: From the French CANCERVIH network.
        Bull Cancer. 2021; 108: 908-914
        • Horner M.J.
        • Shiels M.S.
        • Pfeiffer R.M.
        • et al.
        Deaths Attributable to Cancer in the US Human Immunodeficiency Virus Population During 2001–2015.
        Clin Infect Dis. 2021; 72: e224-e231
        • Altekruse S.F.
        • Shiels M.S.
        • Modur S.P.
        • et al.
        Cancer burden attributable to cigarette smoking among HIV-infected people in North America.
        AIDS. 2018; 32: 513-521
        • Rihana N.
        • Nanjappa S.
        • Sullivan C.
        • et al.
        Malignancy Trends in HIV-Infected Patients Over the Past 10 Years in a Single-Center Retrospective Observational Study in the United States.
        Cancer Control. 2018; 25 (1073274818797955)https://doi.org/10.1177/1073274818797955
        • Ledgerwood D.M.
        • Yskes R.
        Smoking cessation for people living with HIV/AIDS: a literature review and synthesis.
        Nicotine Tob Res. 2016; 18: 2177-2184
        • Smith R.A.
        • Andrews K.S.
        • Brooks D.
        • et al.
        Cancer screening in the United States, 2019: a review of current American Cancer Society guidelines and current issues in cancer screening.
        CA Cancer J Clin. 2019; 69: 184-210
        • Stanton C.A.
        • Papandonatos G.D.
        • Shuter J.
        • et al.
        Outcomes of a tailored intervention for cigarette smoking cessation among latinos living with HIV/AIDS.
        Nicotine Tob Res. 2015; 17: 975-982
        • Stewart D.B.
        • Gaertner W.B.
        • Glasgow S.C.
        • et al.
        The american society of colon and rectal surgeons clinical practice guidelines for anal squamous cell cancers (Revised 2018).
        Dis Colon Rectum. 2018; 61: 755-774
        • Revollo B.
        • Videla S.
        • Llibre J.M.
        • et al.
        Routine screening of anal cytology in persons with human immunodeficiency virus and the impact on invasive anal cancer: a prospective cohort study.
        Clin Infect Dis. 2020; 71: 390-399
      7. New York State Department of Health AIDS Institute. Screening for anal dysplasia and cancer in patients with HIV.
        (Available at:)
        • Engels E.A.
        • Yanik E.L.
        • Wheeler W.
        • et al.
        Cancer-attributable mortality among people with treated human immunodeficiency virus infection in North America.
        Clin Infect Dis. 2017; 65: 636-643
        • Ioannou G.N.
        • Green P.K.
        • Beste L.A.
        • et al.
        Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C.
        J Hepatol. 2018; 69: 1088-1098
        • Loomba R.
        • Lim J.K.
        • Patton H.
        • et al.
        AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.
        Gastroenterology. 2020; 158: 1822-1830
        • Lakshmi S.
        • Beekmann S.E.
        • Polgreen P.M.
        • et al.
        HIV primary care by the infectious disease physician in the United States - extending the continuum of care.
        AIDS Care - Psychol Socio-Medical Asp AIDS/HIV. 2018; 30: 569-577
        • Singh H.K.
        • Del Carmen T.
        • Freeman R.
        • et al.
        From One Syndrome to Many: Incorporating Geriatric Consultation Into HIV Care.
        Clin Infect Dis. 2017; 65: 501-506
        • Erlandson K.M.
        • Karris M.Y.
        HIV and Aging: Reconsidering the Approach to Management of Comorbidities.
        Infect Dis Clin North Am. 2019; 33: 769-786
        • Thompson M.A.
        • Horberg M.A.
        • Agwu A.L.
        • et al.
        Primary Care Guidance for Persons with Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America.
        Clin Infect Dis. 2021; https://doi.org/10.1093/cid/ciaa1391
      8. Home page | United States Preventive Services Taskforce.
        (Available at:) (Accessed August 24, 2022)
      9. HIV Infection and Cancer Risk - NCI.
        (Available at:) (Accessed August 24, 2022)
        • Coghill A.E.
        • Pfeiffer R.M.
        • Shiels M.S.
        • et al.
        Excess mortality among HIV-infected individuals with cancer in the United States.
        Cancer Epidemiol Biomarkers Prev. 2017; 26: 1027-1033
        • Edelman E.J.
        • Gordon K.S.
        • Glover J.
        • et al.
        The next therapeutic challenge in HIV: Polypharmacy.
        Drugs and Aging. 2013; 30: 613-628
        • Ware D.
        • Palella F.J.
        • Chew K.W.
        • et al.
        Prevalence and trends of polypharmacy among HIV-positive and -negative men in the Multicenter AIDS Cohort Study from 2004 to 2016.
        PLoS One. 2018; 13: 1-14
        • Gandhi T.K.
        • Hussar D.A.
        • Minsk A.G.
        Adverse drug events in ambulatory care prescriptions for improvement.
        Med Crossfire. 2003; 5: 21-24
        • Erlandson K.M.
        • Allshouse A.A.
        • Jankowski C.M.
        • et al.
        Risk factors for falls in HIV-infected persons.
        J Acquir Immune Defic Syndr. 2012; 61: 484-489
        • Davis A.J.
        • Greene M.
        • Siegler E.
        • et al.
        Strengths and Challenges of Various Models of Geriatric Consultation for Older Adults Living With Human Immunodeficiency Virus.
        Clin Infect Dis. 2022; 74: 1101-1106
        • Kay E.S.
        • Batey D.S.
        • Mugavero M.J.
        The HIV treatment cascade and care continuum: updates, goals, and recommendations for the future.
        AIDS Res Ther. 2016; 13: 35